Shelley Shaw

VP Oncology Marketing Japan Astellas Pharma

Seminars

Wednesday 20th May 2026
Successfully Co-Launching a Novel CDx & Oncology Treatment to Enable Patient Access to Life-Changing Therapies
2:30 pm
  • Best practice examples of launching novel CDx and oncology therapies to ensure streamlined market access
  • Considering the challenges and priorities of simultaneously commercialising CDx and precision therapies
Shelley Shaw - Head of Oncology Marketing, Astellas